uniQure N.V. (NASDAQ: QURE) Stock Information | RedChip

uniQure N.V. (NASDAQ: QURE)


$6.0100
+0.2300 ( +2.39% ) 233.7K

uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.

Market Data


Open


$6.0100

Previous close


$5.7800

Volume


233.7K

Market cap


$301.72M

Day range


$5.7800 - $6.2350

52 week range


$3.7300 - $11.3500

SEC Filings


Form Type Description Pages Date
4 Insider transactions 1 Jun 20, 2024
8-k 8K-related 14 Jun 20, 2024
4 Insider transactions 1 Jun 18, 2024
4 Insider transactions 1 Jun 17, 2024
4 Insider transactions 1 Jun 17, 2024
4 Insider transactions 1 Jun 17, 2024
4 Insider transactions 1 Jun 17, 2024
4 Insider transactions 1 Jun 17, 2024
4 Insider transactions 1 Jun 17, 2024
4 Insider transactions 1 Jun 17, 2024

Latest News